$Novo Nordisk AS(NVO.US) management initiated a 12-month, $2.5 billion reverse share repurchase program starting this February. The repurchased shares will be used to enhance the value of existing shareholders' stock. This move indicates that the leadership is confident about performing better in the next 1-3 years. Furthermore, the collaboration with OpenAI is an indispensable partnership for advancing healthcare and keeping pace with the times. This is the inevitable direction! In summary, hold on to what you have. For those brothers trapped at high positions, it's about value investing.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
